CD69 expression on airway eosinophils and airway inflammation in a murine model of asthma

Chinese Medical Journal

Volumn 119, Issue 23, 2006, Pages 1983-1990

  Wang, Hui Ying ^a   Shen, Hua Hao ^a   Lee, James J ^b   Lee, Nancy A ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Airway inflammation; Asthma; CD69; Eosinophils; Murine model

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; OKT 4; OVALBUMIN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ASTHMA; C57BL MOUSE; CONTROLLED STUDY; EOSINOPHIL COUNT; FLOW CYTOMETRY; IN VITRO STUDY; LUNG LAVAGE; MOUSE; NONHUMAN; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; CYTOLOGY; EOSINOPHIL; IMMUNOLOGY; INFLAMMATION; LUNG; PATHOPHYSIOLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILS; INFLAMMATION; LUNG; MICE; MICE, TRANSGENIC;

EID: 33847142850     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200612010-00008     Document Type: Article

References (35)

1. Sugita M, Kuribayashi K, Nakagomi T, Miyata S, Matsuyama T, Kitada O. Allergic bronchial asthma: airway inflammation and hyper-responsiveness. Intern Med 2003; 42: 636-643.
2. Shen HH. Eosinophil: central mediator of allergic asthma? Chin Med J 2005; 118:4-5.
3. Busse WW, Lemanske RF J. Asthma. N Engl J Med 2001; 344: 350-362.
4. Busse WW, Calhoun WF, Sedgwick JD. Mechanism of airway inflammation in asthma. Am Rev Respir Dis 1993; 147 (6 Pt 2): S20-S24.
5. Leigh R, Ellis R, Wattie JN, Hirota JA, Matthaei KI, Foster PS, et al. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med 2004; 169: 860-867.
6. Trifilieff A, Fujitani Y, Coyle AJ, Kopf M, Bertrand C. IL-5 deficiency abolishes aspects of airway remodelling in a murine model of lung inflammation. Clin Exp Allergy 2001; 31: 934-942.
7. Hamelmann E, Gelfand EW. Role of IL-5 in the development of allergen-induced airway hyperresponsiveness. Int Arch Allergy Immunoll 1999; 120: 8-16.
8. Cohn LR, Homer J, MacLeod H, Mohrs M, Brombacher F, Bottomly K. Th2-induced airway mucus production is dependent on IL-4Rα, but not on eosinophils. J Immunol 1999; 162: 6178-6183.
9. Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG, Foster PS. A novel T cell-regulated mechanism modulating allergen induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol 1998; 61: 1501-1509.
10. Coyle AJ, Kohler G, Tsuyuki S, Brombacher F, Kopf M. Eosinophils are not required to induce airway hyperresponsiveness after nematode infection. Eur J Immunol 1998; 28: 2640-2647.
11. Birrell MA, Battram CH, Woodman P, McCluskie K, Belvisi MG. Dissociation by steroids of eosinophilic inflammation from airway hyperrespon-siveness in murine airways. Respir Res 2003; 4:1-7.
12. Xie ZF, Shi HZ, Qin XJ, Kang LF, Huang CP, Chen YQ. Effects of antigen presentation of eosinophils on lung Th1/Th2 imbalance. Chin Med J 2005; 118: 6-11.
13. Shen HH, Ochkur SI, McGarry MP, Crosby JR, Hines EM, Borchers MT, et al. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol 2003; 170: 3296-3305.
14. Lensmar C, Katcher K, Eklund A, Grunewald J, Wahlstrom J. Phenotypic analysis of alveolar macrophages and lymphocytes following allergen inhalation by atopic subjects with mild asthma. Respir Med 2006; 100:918-925.
15. Lee NA, McGarry MP, Larson KA, Horton MA, Kristensen AB, Lee JJ. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunoll 1997; 158: 1332-1344.
16. + T cell-dependent airway mucus production occurs in response to IL-5 expression in lung. Am J Physiol Lung Cell Mol Physiol 2002; 282: L1066-1074.
17. Pabst R. Animal models for asthma: controversial aspects and unsolved problems. Pathobiology 2002-2003; 70: 252-254.
18. Malm-Erjefalt M, Persson CG, Edefalt JS. Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. Am J Respir Cell Mol Biol 2001; 24: 352-359.
19. Denzier KL, Borchers MT, Crosby JR, Cieslewicz G, Hines EM, Justice JP, et al. Extensive eosinophils degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovabulmin-challenge model of pulmonary inflammation. J Immunol 2001; 167: 1672-1682.
20. Denzier KL, Farmer SC, Crosby JR, Borchers M, Cieslewicz G, Larson KA, et al. Eosinophil major basic protein-1 does not contribute to allergen- induced airway pathologies in mouse models of asthma. J Immunol 2000; 165: 5509-5517.
21. Vance BA, Harley PH, Backlund PS, Ward Y, Phelps TL, Gress RE. Human CD69 associates with an N-termianal fragment of calreticulin at the cell surface. Arch Biochem Biophys 2005; 438:11-20.
22. Lewkowich IP, Rempel JD, HayGlass KT. Prevention of allergen-specific, Th2-biased immune responses in vivo: role of increased IL-12 and IL-18 responsiveness. J Immunol 2005; 175: 4956-4962.
23. Hartnell A, Robinson DS, Kay AB, Wardlaw AJ. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 1993; 80: 281-286.
24. Matsumoto K, Appiah-Pippim J, Schleimer RP, Bickel CA, Beck LA, Bochner BS. CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. Am J Respir Cell Mol Biol 1998; 18: 860-866.
25. Park CS, Choi EN, Kim JS, Choi YS, Rhim TY, Chang HS, et al. Interferon-gamma inhibits in vitro mobilization of eosinophils by interleukin-5. Int Arch Allergy Immunol 2005; 136: 295-302.
26. Ishihara C, Ochiai K, Kagami M, Takashahi H, Matsuyama G, Yoshida S, et al. Human peripheral eosinophils express functional interferon-gamma receptors (IFN-gammaR). Clin Exp Immunol 1997; 110: 524-529.
27. Lopez JA, Newburger PE, Condino-Neto A. The effect of IFN-gamma and TNF-alpha on the eosinophilic differentiation and NADPH oxidase activation of human HL-60 clone 15 cells. J Interferon Cytokine Res 2003; 23: 737-744.
28. Trifilieff A, Fujitani Y, Coyle AJ, Kopf M, Bertrand C. IL-5 deficiency abolishes aspects of airway remodelling in a murine model of lung inflammation. Clin Exp Allergy 2001; 31: 934-942.
29. Ip WK, Wong CK, Wang CB, Tian YP, Lam CW. Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor induce adhesion and chemotaxis of human eosinophilsinophils via p38 mitogen-activated protein kinase and nuclear factor kappaB. Immunopharmacol Immunotoxicol 2005; 27: 371-393.
30. Vassina EM, Yousefi S, Simon D, Zwicky C, Conus S, Simon HU. cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis. Eur J Immunol 2006 36: 1975-1984.
31. Stout BA, Bates ME, Liu LY, Farrington NN, Bertics PJ. IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol 2004; 173: 6409-6417.
32. Yamamoto H, Sedgwick JB, Vrtis RF, Busse WW. The effect of transendothelial migration on eosinophils function. Am J Respir Cell Mol Biol 2000; 23:379-388.
33. Hahn C, Islamian AP, Renz H, Nockher WA. Airway epitheliall cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation. J Allergy Clin Immunol 2006; 117: 787-794.
34. Shinkai K, Mohrs M, Locksley RM. Helper T cells regulate type-2 innate immunity in vivo. Nature 2002; 420: 825-829.
35. + T cell and eosinophil adhesion is mediated by specific ICAM-3 ligation and results in eosinophil activation. J Immunol 2000; 164: 3385-3391.